Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q1 2026
Institutional positions in Calidi Biotherapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +2 vs. Q4 2025
- Shares held
- 2.01M
- +1.59M (+385.5%) vs. Q4 2025
- Total value
- $478.8K
- −$5.26K (−1.1%) vs. Q4 2025
- New holders
- 7
- 7 more added
- Sold out
- 5
- 3 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $655.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.53M |
| Q4 2023 | 25 | $2.83M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $39.0M |
| Q1 2023 | 27 | $40.6M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $205.5M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $164.7M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 14 | $3 | 0.00% | +13+1,300.0% | Added |
| CVA Family Office, LLC | 42 | $10 | 0.00% | 00.0% | Unchanged |
| Reyes Financial Architecture, Inc. | 100 | $24 | 0.00% | 00.0% | Unchanged |
| Tradewinds Capital Management, LLC | 101 | $25 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 115 | $27 | 0.00% | +69+150.0% | Added |
| FMR LLC | 255 | $61 | 0.00% | −21,758−98.8% | Reduced |
| Highbridge Capital Management LLC | 1,042 | $248 | 0.00% | 00.0% | Unchanged |
| Apollo Management Holdings, L.P. | 1,042 | $249 | 0.00% | 00.0% | Unchanged |
| Finepoint Capital LP | 1,042 | $249 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,396 | $333 | 0.00% | −1,378−49.7% | Reduced |
| Advisor Group Holdings, Inc. | 2,106 | $503 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,133 | $2.00K | 0.00% | +10,133 | New |
| Vanguard Fiduciary Trust Co | 9,219 | $2.20K | 0.00% | +9,219 | New |
| Morgan Stanley | 9,467 | $2.26K | 0.00% | +8,000+545.3% | Added |
| Farther Finance Advisors, LLC | 10,000 | $2.43K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,758 | $4.24K | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 19,921 | $4.76K | 0.00% | −50−0.3% | Reduced |
| Vanguard Capital Management LLC | 25,509 | $6.10K | 0.00% | +25,509 | New |
| Jane Street Group, LLC | 34,802 | $8.31K | 0.00% | +23,311+202.9% | Added |
| SRS Capital Advisors, Inc. | 37,345 | $8.92K | 0.00% | +37,345 | New |
| RS Crum Inc. | 40,256 | $9.61K | 0.00% | +20,000+98.7% | Added |
| Geode Capital Management, LLC | 63,019 | $15.0K | 0.00% | +21,090+50.3% | Added |
| Virtu Financial LLC | 75,769 | $18.0K | 0.00% | +54,526+256.7% | Added |
| HighTower Advisors, LLC | 83,523 | $19.9K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 250,000 | $59.5K | 0.02% | +250,000 | New |
| Sabby Management, LLC | 434,903 | $103.9K | 1.82% | +434,903 | New |
| Armistice Capital, LLC | 879,000 | $209.9K | 0.01% | +879,000 | New |
| Evermay Wealth Management LLC | 1 | – | – | 00.0% | Unchanged |
| DRW Securities, LLC | 0 | $0 | 0.00% | −147,767−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −7,514−100.0% | Sold out |
| Barrett & Company, Inc. | 0 | $0 | 0.00% | −292−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |